Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors

CONCLUSION: This analysis described Ki67 in different subtypes in EBC and its association with clinicopathological factors. According to more aggressive tumor biology, the respective subgroups also showed higher median Ki67 levels. However, definition of low and high proliferation index itself is difficult. It is essential to interpret Ki67 indices carefully with regard to the own institutional values and other clinicopathological factors.PMID:34535596 | DOI:10.1159/000517490

Source: Oncology - September 18, 2021 Category: Cancer & Oncology Authors: Amelie de Gregorio Thomas Wolfram Paul Friedl Eva Hering Peter Widschwendter Nikolaus de Gregorio Inga Bekes Wolfgang Janni Davut Dayan Jens Bodo Huober Source Type: research